Winter environmental conditions raise questions around eye cream formulation and the functional role of Manihot ...
In December 2025, Palvella requested a Preliminary Breakthrough Therapy Designation Advice meeting with the FDA which is anticipated for the first quarter of 2026. The Company plans to commence a ...
Fruchter, G. (2026) Opportunism in Supply Chain Recommendations: A Dynamic Optimization Approach. Modern Economy, 17, 26-38.
ISLAMABAD: Prime Minister Shehbaz Sharif on Friday said the federal government has established a transparent system to ...
NASA is ramping up work on one large space telescope while also laying the groundwork for future observatories.
Company on track to report topline results early in the second quarter of 2026 Second planned Data and Safety Monitoring Board (DSMB) meeting evaluated all available ...
Last year, the United States launched a wave of tariff actions worldwide. Against the backdrop of escalating Sino-US tariff ...
That responsibility sits with Brett Roosendaal, commercial nutrition executive at Rainbow Chicken Farms and speaker at New ...
11d
Merck: A Pharma Giant Trading At A Decade-Low Valuation While Executing Its Post-Keytruda Playbook
Merck (MRK) looks undervalued amid 2028 Keytruda patent fears—strong Q3 results, pipeline wins, and 12x P/E suggest upside.
U.S. Food and Drug Administration (FDA) allows advancement of RAP-219 into registrational trials for focal onset seizures (FOS); accelerated ...
Examination of transdermal berberine delivery, GLP-1 pathway terminology in supplement marketing, and consumer evaluation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback